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I. INTRODUCTION
Olympic athletes do it.1 The Navy does it.2 Even President Reagan does it.3
Drug testing is a reality in today's society. While scholars and civil libertarians debate
constitutional 4 and privacy concerns, 5 thousands of urine samples are analyzed daily
to detect the presence of marijuana, cocaine, heroin, amphetamines, barbiturates, and
other mood-altering substances. 6 A positive test result may never be forgotten by an
applicant denied a job, a college athlete forced to sit out a bowl game, or the family
of an accident victim killed by an impaired worker's negligence. 7
The proliferation of drugs in modem society has caused many employers to look
to drug screening programs to accomplish certain goals. A primary concern is the
desire to deter drug use in the workplace. 8 Employers hope that screening can help
promote a safer work environment and help eliminate drug-related accidents or
illness. 9 Employers may also wish to protect themselves from liability for an impaired
worker's negligence.' 0 Many employers desire to eliminate potential substance
abusers from a particular pool of applicants before making a substantial investment
in training and education. Pre-employment screening is one method used to
accomplish that goal."
On the other hand, many employees find something "fundamentally offensive"
about submitting urine samples to an employer on demand. 12 One reason is that
sometimes individuals are required to urinate under observation to safeguard against
1. Catlin, Kammerer, Hatton, Sekera & Merdink, Analytical Chemistry at the Games of the XXlrd Olympiad in
Los Angeles, 1984, 33 Ct.weA. Ctrat. 319 (1987).
2. Hanson, Drug Abuse Testing Programs Gaining Acceptance in Workplace, CHEt. & ENG'G NEws, June 2, 1986,
at 8.
3. Kaufman, The Battle Over Drug Testing, N.Y. Times, Oct. 19, 1986 (Magazine), at 52.
4. The fourth amendment to the U.S. Constitution prohibits the government from conducting unreasonable
searches and seizures. While the fourth amendment does apply to drug testing programs for public employees, National
Treasury Employees Union v. Von Raab, 816 F.2d 170, 176 (5th Cir. 1987), searches and seizures by private employers
are not regulated by the fourth amendment. See 9A Lab. Rel. Rep. (BNA) 509:103 (Jan. 1987). An analysis of the
constitutional issues of drug testing is beyond the scope of this Article.
5. Some state constitutions have specific right of privacy provisions that apply to private action, as well as
governmental activities. See, e.g., White v. Davis, 13 Cal. 3d 757, 533 P.2d 222, 120 Cal. Rptr. 94 (1975) (discussing
CAL. Cossr. art. I, § I which provides: "All people are by nature free and independent and have inalienable rights. Among
these are enjoying and defending life and liberty, acquiring, possessing, and protecting property, and pursuing and
obtaining safety, happiness, and privacy.").
6. Rust, The Legal Dilemma, A.B.A. J., Nov. 1, 1986, at 51.
7. Stille, Drug Testing: The Scene Is Set for a Dramatic Legal Collision Between the Rights of Employers and
Workers, NAT'L L.J., Apr. 7, 1986, at 1, col. 1; Neff, Bosworth Faces the Music, SroRes .lus., Jan. 5, 1987, at 21; Otis
Eng'g Corp. v. Clark, 668 S.W.2d 307 (Tex. 1983). Families of automobile accident victims brought this wrongful death
action against an employer who sent an intoxicated employee home.
8. P. BusGE, DRUGs is THE WoeRKK'.AcE: Eurs.ovess' RIsasa AN REseosllmnmls 1 (Wash. Legal Found.
Monograph, 1984).
9. Id.
10. Id. at 7.
11. Id. at 16-20.
12. Cohen, Labor Law's New Specialty: Drug Testing, Am. L4,wyT, June, 1986, at 10.
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sample tampering.1 3 Other applicants or employees may be reluctant to disclose to
their employers that they have a medical condition such as epilepsy. Epilepsy is often
controlled by prescription medication detectable in a urine drug screen.14 Many
individuals also have concerns about the accuracy of the testing process. A mistake
at any step in the drug testing process could cause an innocent person to be labeled
a drug user. Disastrous consequences may follow. The employee or applicant may
not only lose employment, but also carry a lifelong stigma.
The first part of this Article discusses drug testing methodology and the
reliability of the tests. The second part discusses currently available remedies for
private sector employees who challenge the tests, and examines some challenges to
reliability that have been made in the courts. Finally, legislation is recommended as
a means of protecting workers from unregulated laboratories and inadequate testing
procedures.
II. TESTING
A. Methodology
1. Initial Testing
Much of the debate over drug testing focuses on the accuracy and reliability of
the tests. Before one can appreciate the concerns over accuracy and reliability of
results, it is important to receive an overview of drug testing methodology. Several
methods are used as initial screens for a variety of drugs. The most common methods
are thin layer chromatography (TLC), enzyme immunoassay (EIA), and radioim-
munoassay (RIA). t5
In the TLC method, a drop of chemically treated urine extract is put on a glass
plate coated with a thin layer of silica gel. The plate is put into a solvent that moves
up the plate by capillary action.1 6 Drugs that are present in the urine extract are
carried up the plate along with the solvent. Drugs are identified when a dye solution
is sprayed onto the plate. The solution reacts with the drugs, causing colored spots to
appear. A technologist matches the color and location of the spots on the plate with
known standards. This reading of the plates requires a high degree of skill.17 After a
few minutes many of the spots fade away, leaving no permanent record of the test.' 8
Many clinical reference laboratories use TLC for preliminary screening followed by
13. Conference Examines Accuracy of Drug Tests, I INoivmuAL E. uovsiE RIGHTs (BNA) 4 (Dec. 9, 1986); Capua
v. City of Plainfield, 643 F. Supp. 1507 (D.N.J. 1986).
14. "Consideration should be given to the fact that sufficient discrimination still exists in our society and that
individuals with these particular conditions may have been actively hiding them from their coworkers or employers."
NATIONAL INsmrrs ON DRUG AtUSE, URINE Trs'rrG FOR DRUGS OF ABUSE 2 (NIDA Research Monograph No. 73, 1986); see
M. RornisrE, MEDICAL SCREEnNG OFWo seS, 204 (1984).
15. L. DOGOLOFr & R. ANGAROLA, URINE Tts-rNc IN THE WORKPLACE 18 (1985).
16. Capillary action is the phenomenon in which the level of fluid inside an open tube of very small diameter is
higher or lower than the level of the surrounding fluid as a direct result of interfacial or surface tension. 5 E&cYctoPEIA
ArtlERCANA Capillarity 593 (1983).
17. L. DoOLOni & R. ANGAROLA, supra note 15, at 18.
18. Id.
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a confirmation test conducted by another method. 19 Confirmation by another method
of initially positive results can help eliminate the problem of false positives. The
advantages of the TLC method include both its ability to distinguish between closely
related compounds20 and its relatively low cost.21 Alternatively, the disadvantages
are the high degree of expertise required to read results and the number of false
positives that are generated. 22
The immunoassays (EIA and RIA) are the most widely used methods for large
scale drug screening programs. 23 These tests were specifically designed to detect the
classes of drugs that are most commonly abused. 24 Both methods use antibodies to
detect drugs. 25 If a specific drug is present in urine, the antibody to that drug or
metabolite reacts with a test mixture (reagent) antigen. 26 These levels are usually
measured in billionths of a gram (nanograms). 27 Even though a small quantity of the
drug may be present, anything detected below the cutoff level will be reported as
negative. 28 The cutoff level is the lowest amount of the drug which can be reliably
detected by the procedure;29 technical limitations of the procedure make a positive
result uncertain below the cutoff level.30 The methods have different cutoff levels,
and there is variation in cutoff levels from laboratory to laboratory. 3'
The EIA method causes an absorbance in enzyme activity change which is
measured by a device called a spectrophotometer. 32 The EIA method is often chosen
for on-site testing away from a laboratory. For example, the Syva Company
manufactures a desk-top sized test kit called EMIT which uses the EIA method. 33 The
primary advantages of the EIA method are ease of testing and low cost. Nontechnical
people can be trained to operate the equipment. The primary disadvantage of this
method is that interfering substances sometimes cause inaccurate results. 34
The RIA method gives off a low level of radiation which is measured by a
gamma counter.35 The RIA method must be used in a laboratory that is licensed to
handle radioactive materials. The scientific community considers this method quite
19. Hanson, supra note 2, at 9.
20. Id.
21. L. Dooowttr & R. ANG.RoLA, supra note 15, at 18.
22. Id.
23. Hanson, supra note 2, at 9. E.g., since 1985 the Department of Defense has used the RIA method for drug
screening in the armed forces. Prior to June 1, 1985, both the EIA and RIA methods were used by the armed forces.
Accuracy concerns appear to be the reason the EIA method was dropped. In re Syva Co., Decision of the Comptroller
General of the U.S., File B-218359.2 (Aug. 22, 1985).
24. The classes are amphetamines, barbiturates, benzodiazepines, cannabinoids (marijuana), cocaine,
methaqualone, opiates (including heroin), and phencyclidine (PCP). L. DoooLonF & R. ANOARO"A, supra note 15, at
18-19.
25. Id. at 19.
26. For a layperson's explanation of the EIA technique, see Higgs v. Wilson, 616 F. Supp. 226, 228 (D.C. Ky.
1985).
27. L. DooLor & R. ANGAroeA, supra note 15, at 21-22.
28. Id. at 22.
29. Id.
30. Id.
31. Id.
32. Emit d.a.u. Amphetamine Assay, 3C124-1, § 3 (Sept. 1984) (manufacturer's instruction booklet).
33. L. DoGoLoFF & R. ANGAROLA, supra note 15, at 19.
34. Id.
35. Id.
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accurate. Its disadvantages consist of the need for a laboratory licensed to handle
radioactive materials and its inability to test for some commonly abused drugs, such
as methadone, PCP, librium, and valium. 36 Also, it is more expensive than the EIA
test. 37
2. Confirmation Testing
Toxicologists and the manufacturers of these tests recommend that all initially
positive results be confirmed by another method to ensure accuracy. 38 The purpose of
this two-tiered system is to eliminate false positives caused by cross-reactivity.
Cross-reactivity occurs when compounds that are chemically similar to the drug or its
metabolite cause a false reading. 39 For example, some over-the-counter cold pills and
diet pills can produce a positive amphetamine result.40
There are several different ways to confirm initially positive results. The least
reliable method is simply to repeat the original assay using the same method. While
this method of confirmation may help to eliminate human error in the testing process,
it does nothing to correct the problems of cross-reactivity or interfering compounds
in the test itself.41 At one point early in the Navy's testing program, the laboratory in
Oakland, California had a huge backlog of samples to test.42 In some cases the
laboratory simply used a second RIA test to confirm the first positive RIA results. 43
Consequently, disciplinary actions taken against 3000 people on the basis of those
test results were reversed. 44
A more reliable method of confirmation is to confirm all initially positive results
with the use of another screening method (for example, TLC followed by EIA or
RIA).45 The director of a forensic chemistry laboratory has noted, "[a]ny positive test
result really needs to be confirmed by a method that is more specific, more reliable,
and at least as sensitive as the initial screen." 46
The most sophisticated state-of-the-art confirmatory method is called gas
chromatography/mass spectrometry (GC/MS). 47 GC/MS breaks different compounds
into electrically charged ion fragments, allowing for positive identification. 48 GC/MS
is not a practical screening method for three main reasons. First, it is prohibitively
more expensive than the other assays;49 second, the method involves the use of
sophisticated equipment; and third, it takes highly trained technologists to perform
36. Hanson, supra note 2, at 9.
37. Id.
38. Id.
39. L. DooLoFF & R. ANGAo.A, supra note 15, at 20.
40. Id.
41. Storms v. Coughlin, 600 F. Supp. 1214, 1225 (S.D.N.Y. 1984).
42. Hanson, supra note 2, at 8.
43. Id.
44. Id.
45. Id. at 10.
46. Id. (quoting Randall C. Baselt, founder and director of the Chemical Toxicology Institute in Foster City,
California).
47. L. DooowoFn & R. ANGAROLA, supra note 15, at 20.
48. Id.
49. Id.
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the tests.50 Even though GC/MS is not a practical screening method, the most
accurate testing method available today is an initial screening test followed by
GC/MS confirmation of all positive results.51
B. Reliability
Regardless of which method or combination of methods is used to test for drugs,
there will always be some incorrect results. These false results may be caused by a
variety of factors.
1. Limitations of the Assays
Because the methodology of the immunoassays (EIA and RIA) is based on
immune reactions, a certain degree of cross-reactivity occurs among various drug
metabolites and structurally similar compounds of a particular drug.52 For example,
patients being treated for rheumatoid arthritis and osteoarthritis with ibuprofen 3 and
fenoprofen may elicit a false positive for marijuana use. 54 This is due to interference
between the compounds in these anti-inflammatory drugs and a popular Syva
cannabinoid assay. Although the manufacturer of that particular assay reported in the
summer of 1986 that it had reformulated the assay to eliminate this problem,55 other
false results can come from ingesting certain over-the-counter diet pills and cold
medications that may give false amphetamine readings.5 6
Eating poppy seed cakes, which naturally contain some morphine, can cause an
individual to have a positive urine test result for opiates.5 7 The tests cannot
distinguish between an ingestion of morphine from poppy seeds and an injection of
heroin, since the result for either is a true positive for morphine.5 8 Similarly, a drug
analysis cannot differentiate between a person who is taking legally prescribed
medication such as phenobarbital for epilepsy and a person who is abusing the drug
without a prescription. Both will show positive results because the drug is present.
Drinking certain brands of herbal tea can also cause a person to have a positive
urine test for cocaine metabolite.5 9 These teas actually contain enough cocaine to
cause intoxication. The results from eating poppy seeds or drinking herbal tea are not
correctly classified as false positives because the compounds are actually present in
the urine. They are instead true positives, even though the results may not be caused
by drug abuse.60
50. Id.
51. Id.
52. Hanson, supra note 2, at 10.
53. A popular over-the-counter brand of this drug is sold under the name Advil.
54. Facts About Emit d.a.u. and Emit stAssays andAnti-Inflammatory Drugs, SYvA NErs RPoRr I (Summer 1986)
[hereinafter Facts About Emit]; Hanson, supra note 2, at 11.
55. Facts About Emit, supra note 54, at 1.
56. Hanson, supra note 2, at 10; L. Doo ow & R. ANssotoA, supra note 15, at 20.
57. Answers to Your Questions, SivA NEws REnorsr 2 (Summer 1986); Hanson, supra note 2, at 11.
58. Hanson, supra note 2, at I1.
59. Answers to Your Questions, supra note 57, at 2.
60. Id.
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2. Failure to Confirm
In addition to inaccurate results from the testing procedures themselves, other
factors such as lack of proper confirmation can lead to erroneous results. For
example, a recent study on the accuracy of EIA and RIA screening procedures for
THC (the active ingredient in marijuana) was conducted at the Army Forensic Drugs
Testing Laboratory at Fort Meade, Maryland. 61 Thousands of urine samples were
field tested by nonlaboratory personnel using the EMIT (EIA) system. 62 Urine
samples were also tested in the laboratory using the RIA method, 63 with positive
samples confirmed by GC/MS. 64 Researchers found a 4% false positive rate and a
10% false negative rate for the EMIT samples. 65 The THC metabolite was detected
by GC/MS in 99.7% of the positive RIA samples. 66 The researchers went on to
conclude:
The identification of what appears to be false presumptive positive samples in the initial
test supports the need to utilize a two-tier test system. Although the number of false
presumptive positives is small, the consequences of a positive drug test result for the
individual concerned are so severe that only the highest forensic standards are acceptable.67
The study concluded that an initial RIA test confirmed by GCIMS virtually
eliminated the problem of false positives for marijuana. 68
3. Specimen Collection
In order to ensure the validity and integrity of the urine samples that are tested,
a variety of collection procedures exist to minimize opportunities to substitute or alter
samples. To provide absolute assurance that the specimen belongs to a particular
individual, direct observation must be used. Direct observation, however, raises
privacy concerns that disturb the sensibilities of many individuals. 69 Recently,
articles explaining how to foil test results have found their way into popular
periodicals. 70 Consequently, in order to ensure that an authentic urine sample is
submitted for testing, laboratories that perform the tests offer to their clients
instructions in sample collection procedures. One laboratory recommends the
following procedure:
61. Abercrombie & Jewell, Evaluation of EMIT and RIA High Volume Test Procedures for THC Metabolites in
Urine Utilizing GCIMS Confirmation, 10 J. oF ANALY'nCAL ToyCOLOGy 178 (Sept./Oct. 1986).
62. Id.
63. Id.
64. Id. at 178-79.
65. Id. at 179.
66. Id.
67. Id. at 180.
68. Id.
69. See, e.g., Union Plaza Hotel Culinary Workers Union, Local 226, 88 Lab. Arb. (BNA) 528 (1986) (McKay,
Arb.). The female employee in Union Plaza chose to be fired rather than completely disrobe and urinate in front of another
person. The arbitrator reinstated the employee. See also Lehr & Middlebrooks, Work-Place Privacy Issues and Employer
Screening Policies, I EmPLo E RELATIONS L.J. 407 (Winter 1985/86); Note, Drug Testing in the Workplace: A Legislative
Proposal to Protect Privacy, 13 J. OF LEois. 269, 276-80 (1986).
70. E.g., Foiling the Urine Police, HARPER'S MAGAZINE 26 (Mar. 1987); Greene, Business is Business to Peddler of
Urine, The Columbus Dispatch, Feb. 2, 1987, at 7A, col. 1. Additional methods of thwarting drug testing are listed in
NATnoNAL INsrnurE o, DRuo ABUSE, supra note 14, at 22-23.
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The employee/applicant should be required to empty his pockets and not be permitted to
carry a coat, purse, etc., into the room where they [sic] will provide the specimen. An
observer of the same sex should accompany the individual into the bathroom. In the case of
females, the stall door should be left ajar. The individual's hands should remain in view at
all times. 71
If the need for absolute assurance is less, slightly less intrusive measures are used to
deter tampering with the sample.
If the test is part of a physical exam, the employee/applicant should be asked to disrobe.
Then [sic] he or she may then be examined by a physician or another member of the medical
staff of the same sex as the employee. This will also determine that the employee does not
have a substitute urine sample or materials that could be used to alter the specimen. The
employee should then don a gown, be escorted to a dry room, 72 and asked to provide a
specimen. As an alternative, the site or clinic may use a modified bathroom. 73
The person collecting the sample must check to see if the bottle is warm, the
color is a pale yellow, and the container is one-third to one-half full. 74 Individuals
have been known to dilute the sample with warm water, substitute another person's
"clean" urine for their own, and then run warm water over the container, or alter the
specimen by adding bleach or other materials that might interfere with the results.75
Experts point out the need for forensic standards throughout the entire drug
testing procedure, particularly where reputation, livelihood, incarceration, or the
right to employment is an issue. 76 "Every drug screening case, whether it's
performed on an employee or any person whose future is at stake, really needs to be
considered a forensic case, and one should be handling the sample, conducting the
test, and reporting the results as if one were going to court with it. "77
4. Human Error
The possibility of human error exists at every step in the testing process.
Samples get mixed up or mislabeled. Many human beings handle the specimen as it
goes through a chain of custody. One expert is concerned that "[tihe real room for
error is not with the technology but with administrative error. A human being has to
pick up the sample and put it in the machine. It may sound trivial but it's not. When
the volume of work goes up, the error rate goes up.' '78 Contamination, mishandling,
71. Roche-A Subsidiary of Hoffman-La Roche Inc., Examples ofCollection ProceduresforInsuring Validity and
Integrity of Urine Samples for Drug Testing, TECHNiCAL REVIEW D1AGNoSUcDLm1sio.Ns.
72. "A dry room is a room that has nothing in it that could be used to contaminate the urine, including water."
Id.
73. "A modified bathroom is a bathroom that has blue colored bowl cleaner in the toilet tank (such as Ty-D-Bol).
This prevents dipping water out of the bowl. In addition, the HOT water in the sink should be turned off (cold water may
remain on). If dilution of the specimen is attempted, the bottle will appear blue-green in color and/or will not be warm."
Id.
74. Id. at 2.
75. Id. at 1.
76. NATIONA- ls'rmrTt O DtG ABUSE, E.vLOiE DRUG SCawssNIG 12 (DHHS Publication No. (ADM) 86-1442,
1986).
77. Hanson, supra note 2, at 12 (quoting Randall C. Baselt).
78, Stille, supra note 7, at 24, col. 1 (quoting Dr. Harold M. Bates, a chemist with Metpath Laboratories,
Teterboro, N.J.).
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and sabotage, especially where a drug testing program is conducted on the work site,
can all cause erroneous results.79
Errors in reporting results can also occur. The samples may have been collected
under optimum conditions; the chain of custody may have been properly preserved;
a reputable laboratory may have conducted the assay and performed proper
confirmation tests; yet a simple clerical error such as a transposition of numbers when
reporting results could cause the transmission of incorrect results to the employer.
The following case illustrates the possibility of human error. A correction officer
in New York City was dismissed because a mandatory drug screen indicated there
was cocaine in his urine specimen.80 The officer sought reinstatement, claiming that
clinic personnel had directed him to place his specimen in an unmarked bottle, and
that his bottle was left alongside other unmarked bottles containing the urine
specimens of other persons being tested.8' The court remanded the case for trial on
the factual issue regarding the chain of custody of the sample.8 2 The court observed
that:
[I]f the clinic had included in its routine a simple procedure whereby a person tested
observes his specimen being labelled, and initials a form confirming the accurate labelling,
that would have resolved this proceeding and would also foreclose any future claims of
mislabelling. We cannot simply ignore that there is always a normal routine in place for
avoiding mistakes in the area of medicine and diagnostic tests, but common experience
continues to demonstrate that mistakes nevertheless occur, most often because of human
error.
8 3
1II. REMEDIES
A. Theories of Liability
The common law provides only limited recourse for private sector employees
who object to drug testing procedures.While the employment-at-will doctrine gives
an employer the right to fire an employee for almost any reason, this doctrine is being
steadily eroded by many courts. 84
The law in all 50 states and the District of Columbia recognizes five main
common law duties of employers for the protection of employees. Employers have a
duty to:
(1) provide a safe place to work; (2) provide safe appliances, tools, and equipment for the
work; (3) give warnings of dangers of which the employee might reasonably be expected to
remain in ignorance; (4) provide a sufficient number of suitable fellow employees; and
79. Rothstein, Screening Workers for Drugs: A Legal and Ethical Framework, 11 E.n'jnOi- RH Alom L.J. 422,
427 (1986).
80. Miciotta v. McMickens, 118 A.D.2d 489, 490, 499 N.Y.S.2d 960, 961 (N.Y. App. Div. 1986).
81. Id. at 490, 499 N.Y.S.2d at 961.
82. Id. at 492, 499 N.Y.S.2d at 962.
83. Id. at 491, 499 N.Y.S.2d at 962 (emphasis added).
84. M. Romsnm, supra note 14, at 81-83. Many courts refuse to apply the employment-at-will doctrine where the
dismissal is in bad faith or contrary to public policy.
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(5) promulgate and enforce rules for the conduct of employees which would make the work
safe.85
These duties may encourage employers to institute drug testing programs to assure a
safe work environment. Consequently, as a condition of both pre-employment and
continued employment, applicants and employees often are required to sign blanket
waivers authorizing the company to use medical and personnel records as it deems
necessary.8 6 "Some critics argue that it is a cramped notion of 'consent' that deems
an employee's decision to submit to drug testing on pain of losing his job
'consensual.'" 8 7
For example, the alcohol and drug policy of the Atlantic Richfield Company
requires pre-employment screening "to prevent hiring individuals who use illegal
drugs or individuals whose use of legal drugs or alcohol indicates a potential for
impaired or unsafe job performance. "88 The policy also requires employees to
consent to a blood test, urinalysis, or other drug/alcohol screening if the individual is
suspected of using or being under the influence of drugs or alcohol, or if workplace
conditions justify testing. 89 "An employee's consent to a search is required as a
condition of employment and the employee's refusal to consent may result in a
disciplinary action, including termination, even for a first refusal." 90 Other
employers require employees to submit to testing at unannounced times on a random
basis. 91
The potential for testing abuse remains regardless of which policy is used. An
employee may feel singled out for testing because of conduct unrelated to drug use
which merely angered the employer.92 On the other hand, if a company tests all
employees regardless of whether there is a suspicion of substance abuse, a dangerous
jurisprudential principle might be established that runs counter to the American
notion of presumption of innocence. Although not criminally accused, they are still
being asked to prove they are not guilty of using drugs. 93
Although there have been relatively few challenges to drug testing in the private
sector, one attorney has predicted that "as employers start hitting on socioeconomic
groups that have the financial wherewithal to afford litigation and see it to the end
they will be challenged more often in court." 94
One person who successfully challenged a drug test was Joe W. Wherry. This
employee brought suit against his employer for defamation in Houston Belt and
85. Id. at 83-84.
86. Rothstein, supra note 79, at 427-28.
87. Kaufman, supra note 3, at 66.
88. Loomis, Corporate Approaches-Maintaining Control ofDrugs & Alcohol in the Workplace, in AIDS & DRUG
ABusE N TiE XVoWoRt Ac 129 (1986).
89. Id. at 131.
90. Id.
91. Id. at 178.
92. NA-To.AL INom'rE oN DRuG ABsE, supra note 14, at 11. See also Englade, Who's Hired and Who's Fired,
STuor Lwyv 25 (Apr. 1986); Storms v. Coughlin, 600 F. Supp. 1214, 1223 ("Prisoners may be targeted for testing
simply to harass them."); Kaufman, supra note 3, at 66.
93. Rust, supra note 6, at 54.
94. Id.
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Terminal Railway v. Wherry.95 The worker had fainted on the job. 9 6 The chief
surgeon for his employer ordered two tests to find out why he had fainted: one test
for diabetes, the other a drug screen. 97 The initial drug screen reported a trace of
methadone in the employee's urine. 98 The company first suspended and then
discharged the employee, later circulating a statement that he had been fired for using
methadone. 99 Further testing arranged by the employee showed that there was a
compound in his urine which was similar to methadone, but it was neither methadone
nor any of the other commonly abused drugs.100 The employee first sought help from
the Veterans' Administration on the ground that he was discharged without cause. 101
He then appealed his discharge under the Railway Labor Act. 102 His dismissal was
affirmed by Public Law Board No. 1259, an arm of the National Railroad Adjustment
Board. 103
The employee subsequently brought a defamation action against his employer
for making false statements accusing him of using drugs.'0 4 The employee gained
both compensatory and punitive damages against the railroad, the award being upheld
on appeal.' 0 5 A petition for rehearing was denied in March 1977, over four and
one-half years after he was initially fired. 10 6 The employee had to fight a four-year
battle to clear his name and erase the stigma of being labeled a drug user. It seems
clear in retrospect that a proper confirmation of the initially positive result by GC/MS
could have prevented both the damage to this individual's reputation and the loss of
his source of livelihood.
An action for defamation requires the publication of false statements that
damage the plaintiff. 10 7 Defenses include absolute privilege, qualified privilege, and
truth.'0 8 The element of publication and the defense of privilege render this an
impractical cause of action for most potential plaintiffs, because in many states it is
permissible to wam a present or prospective employer of misconduct of an
employee. 1°9 This places a burden on the employee to show that statements were
made with a reckless disregard for the truth or with actual malice."10
In addition to a cause of action against an employer for defamation, other
potential causes of action are available against employers who mishandle testing.
These include invasion of privacy, negligence, wrongful discharge, and intentional
95. 548 S.W.2d 743 (Tex. Civ. App. 1976).
96. Id. at 746.
97. Id.
98. Id.
99. Id.
100. Id.
101. Id. at 747.
102. Id.
103. Id.
104. Id. at 745.
105. The employee received $150,000 in compensatory damages and $50,000 in exemplary damages. Id. at 746,
753.
106. Id. at 743.
107. PRossER & KE-roN, THE LAw or ToRts 797 (5th ed. 1984).
108. Id. at 815-42.
109. Id. at 827 n.27.
110. L. DoooLOw & R. ANGAROLA, supra note 15, at 15.
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infliction of emotional distress. The lack of drug testing case law in the private sector
may be an indication that these theories are ineffective methods of redress for an
aggrieved individual.
The tort of invasion of privacy does not require publication to activate the cause
of action. " However, it seems unlikely that a plaintiff could prevail in the face of
the employer's common law defense of consent. 2 The employer can argue that the
employee is under no compulsion to be tested; the employee has the option to refuse
the test even if it means losing one's job.113
Negligent dissemination of medical records might be even harder to prove,
because the plaintiff must overcome the defense that there is no physician-patient
relationship between an applicant or employee and a company doctor. 14 In the case
of Finklea v. Tonsey, a manual laborer for a company that used fast-moving presses
took a drug test which disclosed the presence of Darvon in his urine." 5 The medical
director asked the employee to procure a note from his doctor stating what kind of
medication he was taking. 116 The employee had been treated for physical and
emotional problems, and several months prior to the time the drug screen was
conducted had been prescribed a variety of drugs, including Valium, Elavil, and
Darvoset. 17 The medical director telephoned the employee's clinic, where an
unknown source stated the employee "has been receiving various drugs, Valium,
Melaril, Elavil, Biphetamines, Darvoset, and some other tranquilizers.""I8 There
was also conflicting testimony as to whether the employee was taking Thorazine. 119
The medical director recommended that because of the medications the employee was
taking it would be unsafe to continue his employment.' 20 The employee was
discharged. 121
The employee alleged that the medical director acted negligently in speaking to
an unknown person at the clinic who purportedly provided the facts relating to the
employee's medical history. 22 The employee also argued that the medical director
should have inquired into whether the employee in fact suffered any side-effects such
as dizziness or lack of coordination associated with the drugs Elavil and Valium. 123
The employee also argued that the note he gave to the medical director listed
medication he was taking during a period when he was laid off from his job, not the
subsequent period of time when the drug test was conducted. 124
11M. LEHR & MtDDLEBROOKS, supra note 69, at 409-11.
112. Id. at 411. See supra notes 86-91 and accompanying text for a discussion of consent.
113. Rothstein, supra note 79, at 433.
114. M. Roms'mr, supra note 14, at 5-6.
115. 317 Pa. Super. 553, 556, 464 A.2d 460, 462 (1983).
116. Id. at 556, 464 A.2d at 462.
117. Id.
118. Id. at 557, 464 A.2d at 462.
119. Id. at 557-58, 464 A.2d at 462-63.
120. Id. at 558, 464 A.2d at 463.
121. Id.
122. Id. at 557, 464 A.2d at 462-63.
123. Id. at 560, 464 A.2d at 464.
124. Id. at 559. 464 A.2d at 463.
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The appellate court affirmed the trial court's finding that the medical director
was not negligent. 12 First, the court noted that the employee had offered no evidence
suggesting that the medical director should have known the doctor's note was
incorrect. 126 Second, the company policy stated that no one could work in the press
area who used the kinds of medication the employee had been taking. 127 The court
indicated that this blanket policy outweighed testimony that the employee did not
suffer any adverse side-effects from medication and the argument that an individu-
alized exception to the policy should apply. 128 Finally, even if the unknown source
at the clinic had been wrong, and the note which indicated he was taking prescribed
medication was erroneous, the medical director could not be liable for negligence
since the note was provided by the employee himself, and the employee had done
nothing to correct the erroneous impression that it provided up-to-date information. 129
The concurring judge noted that the court had not attempted to define the scope of the
duty a company physician owes to an employee.130 Nor had the court held that a
company physician's duty is "co-extensive with that which is owed where the
doctor-patient relationship does in fact exist." 31
This case illustrates the difficulties a private sector employee faces when
attempting to challenge the conduct of his employer. Rather than attack the findings
of the drug test itself, this employee challenged the conduct of the company's medical
director. When the initial drug screen showed a positive result, the employee may
have felt compelled to justify the result by disclosing that he was taking prescription
medicine, not illegal drugs. He may have hoped that if he revealed his treatment for
physical and emotional problems the company would not fire him. He may have
thought that since he was taking prescribed medication he would not be disciplined
or discharged for illicit drug abuse. However, the company's medical director
apparently was under no duty to warn the employee that the information provided to
the company doctor would be used against him.
An employee who is discharged for violating a substance abuse policy could
allege wrongful discharge on either the theory that the employer breached an implied
covenant of good faith and fair dealing, or that there was a failure to follow an
implied contract or personnel policy. 132 However, where the employee has a policy
difference with the employer, even if based on a concern for ethics or public safety,
prior cases do not guarantee protection to the employee. 133 Many of these wrongful
discharge cases are based on a public policy exception to the employment-at-will
doctrine. 134 Given the recent spate of publicity about the dangers of drug use, an
125. Id. at 555-56, 464 A.2d at 461-62.
126. Id. at 559, 464 A.2d at 463.
127. Id. at 560, 464 A.2d at 464.
128. Id. at 560-61, 464 A.2d at 464.
129. Id. at 560, 464 A.2d at 464.
130. Id. at 561, 464 A.2d at 464.
131. Id.
132. Mills, An Employer's Approach to the AIDS Problem and Employee Responses to Drug and Alcohol Abuse in
the Workplace, in AIDS & DRUG ABUSE IN T E Woranc 67 (1986).
133. PRossER & KFaroN, supra note 107, at 1028.
134. Rothstein, supra note 79, at 433.
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employee would find it exceedingly difficult to prove that a dismissal for drug use
violated a public policy. 135
Finally, an employer who conducts testing in a careless and undignified manner
might be sued for intentional infliction of emotional distress. The requirements are
difficult to satisfy because the conduct must be outrageous, exceeding all bounds
usually tolerated by decent society, and cause serious mental distress. 136 In a suit
pending in California, the plaintiff is challenging an employer's right to randomly test
an employee in the absence of both reasonable suspicion of drug use and impairment
of her work. 137 In response to her employer's request, the plaintiff refused to be tested
and was dismissed. 138 According to her attorney, one reason for her unwillingness to
undergo testing was that she was three months pregnant and had not told anyone at
work about her pregnancy due to a fear that her condition might adversely affect her
career. 139 Her claims include wrongful termination in violation of public policy,
retaliatory discharge for exercise of constitutional rights, invasion of privacy, and
intentional infliction of emotional distress. 140
Another potentially liable party might be the laboratory that performed a drug
analysis and failed to properly confirm an initially positive result. An employee/
applicant who can prove the laboratory did not properly follow the manufacturer's
instructions in performing the test may recover under a theory of negligent testing. 141
Not only the employee but also the employer may attack the credibility of
laboratory results and procedures. An employer has recently filed suit against a major
drug testing laboratory after the employer discovered that it had received legally
indefensible test results from the laboratory. 142 The employer fired a clerk based on
a positive marijuana result. 143 The clerk filed suit against the employer, and the suit
was settled for a cash award and reinstatement. The employer maintains that
laboratory personnel claimed that the initial positive result had been confirmed by a
second, more reliable testing procedure when, in fact, no confirmation had been
made. The employer is suing under theories of negligence, fraud, and deceit in
testing. 44
135. See M. RotrwmN, supra note 14, at 81-83.
136. PRossER & KEETNm, supra note 107, at 60.
137. Luck v. Southern Pacific Trans. Co., No. C84-3-230 (Cal. Super. Ct., S.F. Cty., filed Aug. 5, 1985) (cited
in Stille, supra note 7, at 22).
138. Stille, supra note 7, at 22; Kaufman, supra note 3, at 69.
139. Stille, supra note 7, at 22.
140. Schachter & Geidt, Controlling Workers' Substance Abuse, NAT'L L.J., Nov. 11, 1985, at 20, col. 1.
141. L. Dootovv & R. ANcAaoiA, supra note 15, at 15.
142. San Diego Gas & Elec. Co. v. National Health Laboratories, No. 4380 (San Diego Sup. Ct. filed Apr. 23,
1987).
143. The complaint is summarized in Industrial Relations, Inc., Employee Relations Advisor 11 (L. Souv6 ed.
Apr/May 1987).
144. The employee is seeking recovery of the settlement amount, attorneys' fees, and punitive damages of
$500,000.
1987]
OHIO STATE LAW JOURNAL
B. The Prison Cases
Few reported cases challenging the validity of drug testing have come from the
private sector, but several prison cases illustrate how federal judges have viewed the
accuracy and reliability problem.
In Jenson v. Lick,145 an inmate at the North Dakota state penitentiary challenged
the reliability of the EMIT drug screen manufactured by the Syva Company.146 The
plaintiff claimed the EMIT urinalysis test was inaccurate because it invariably returns
a small percentage of false-positive tests. 147 The court responded by noting that the
Center for Disease Control in Atlanta, Georgia had tested the reliability of the EMIT
procedure and found it to be 97 to 99% accurate.1 48 The court also noted that the
manufacturers of the test claim "testers can act with a 95% confidence in the
accuracy of the test result."' 149 The court concluded that the 95% figure was
"tantamount to almost complete certainty." 150 Consequently, the court held that
whether the proper standard of proof in the prison urinalysis program was "beyond
a reasonable doubt" or "more likely so than not so," the 95% level of reliability was
adequate to support a decision for administrative punishment. 151 The court did not
think that confirmation of a single positive EMIT result was necessarily required by
the program, but indicated that an "inmate claiming the test is false can as part of his
defense contest the specific result through his representative by requiring a confir-
matory test. .... -152 Thus, in this prison context, the court is willing to permit
individuals to be disciplined on the basis of a single, unconfinmed EMIT drug test.
Another opportunity to examine the reliability of the EMIT drug screen arose in
New York. Inmates of the New York state prisons sought an injunction preventing
prison authorities from taking disciplinary action against inmates based on uncon-
firmed urinalysis results. 153 A federal magistrate granted a preliminary injunction
enjoining the prison authorities from taking future disciplinary actions against inmates
based solely on an unconfirmed positive EMIT test, and ordered the prison to begin
confirming all positive EMIT results by another reliable method before using the
results as the sole basis of disciplinary action.15 4 However, the district court held that
the prisoners had not met their burden of demonstrating entitlement to injunctive relief
and denied their motion until a trial on the merits could be held. 155 The court listened
to the testimony of several expert witnesses on the reliability of the EMIT procedure. 1
56
The court summarized the expert's testimony and found error rates from a low of 2.3%
145. 589 F. Supp. 35 (D.N.D. 1984).
146. Id. at 36.
147. Id.
148. Id. at 38.
149. Id. (emphasis in original).
150. Id. at 39 (emphasis in original).
151. Id.
152. Id.
153. Peranzo v. Coughlin, 608 F. Supp. 1504, 1506 (S.D.N.Y. 1985).
154. Id. at 1507.
155. Id. at 1'11-12, 1515.
156. Id. at 1509-12. The New York prison program repeated initially positive EMIT results by performing another
EMIT test. Id. at 1510.
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to a high of 25% in the EMIT procedure. 157 However, the court had narrowed the scope
of its inquiry by saying: "The question, 'How reliable is the test?' is one for scientists
to resolve; the question, 'Is the test sufficiently reliable such that its use as the basis
for imposing disciplinary sanctions against prisoners does not offend constitutional
standards?' is a legal matter to which different standards apply." 158 Therefore, al-
though the court held that additional confirmatory testing was not required as a matter
of due process for prisoners, the court recognized that the additional safeguards of
outside confirmatory testing by TLC would serve a worthwhile purpose.159
In contrast to the preceding cases, two other federal courts have examined the
reliability of the EMIT drug screen in the prison setting and have required additional
evidence to confirm the presence of drugs. In Wykoff v. Resig, 160 a prisoner
challenged the validity of using the TLC method to confirm a positive EMIT drug
screen for marijuana.' 6' The court specifically found that "the TLC method of
confirming an EMIT test is sufficient. Even though Gas Chromatography or Gas
Chromatography/Mass Spectroscopy might be the best methods with which to
confirm an EMIT test, plaintiff has not shown that the TLC method of confirming
positive EMIT results is inadequate or unreliable." 162 Despite this finding, the court
went on to prospectively require that all positive EMIT results in the prison program
be confirmed by a second EMIT test or its equivalent.163 Although stopping short of
requiring an alternate method of confirmation, the court did not think a single,
unconfirmed EMIT test provided a reliable basis for disciplinary action.164
Yet another challenge to the EMIT drug screen arose from inmates in the
Kentucky state prisons. 165 In this case, all the experts testified in favor of the need for
confirmation testing. 166 The prison's own expert first testified that the EMIT test was
reliable without a backup. 167 He then admitted that at an earlier hearing he had stated
that the EMIT test alone was unreliable and any single test should be backed up with
a second test.168 However, he later testified that he did not believe confirmation was
necessary if the individual was either in prison or on parole. 169 He did not explain his
rationale for this double standard. The court looked to state decisions in Massachu-
setts and Vermont which held that "the chance of false positives in unconfirmed
EMIT test results and the concomitant loss of liberty violates minimum fundamental
fairness and the prisoners' due process rights. ' ' 70 The district court found the
evidence before them to be similar to the state case and granted injunctive relief to the
157. Id. at 1511.
158. Id. at 1507.
159. Id. at 1514.
160. 613 F. Supp. 1504 (N.D. Ind. 1985).
161. Id. at 1512.
162. Id.
163. Id.
164. See id. at 1512.
165. Higgs v, Wilson, 616 F. Supp. 226 (W.D. Ky. 1985).
166. Id. at 229.
167. Id.
168. Id.
169. Id.
170. Id. at 230.
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prisoners.171 However, the court stopped short of requiring confirmation of a positive
EMIT drug screen by another method.172 Instead, the court required the prison to
"confirm the test with other evidence-either another alternative method test,
testimony that the accused was seen with contraband[,] ... evidence that drugs were
found in his cell, or other . . . circumstantial evidence .. ,"173
Thus, an examination of the prison cases demonstrates that the reliability issue
is far from settled. Prisoners have had limited success in challenging the constitu-
tionality of some drug testing programs, and in some cases have prevailed when the
lack of proper confirmation procedures violated their due process rights. The prison
cases point out that our society grants some prisoners greater protection than is due
job applicants or employees. A job applicant might be denied a job on the basis of a
single unconfirmed drug test, but a prisoner in Kentucky or Indiana may not be
disciplined on the same basis. Our legal system does not account for the fact that the
same dangers of testing exist whether the tests are conducted by the government or
by a private employer. The private sector workforce is "virtually without remedy due
to the difficulty of establishing an actionable tort, the absence of 'state action,' and
a lack of legislation in this area."' 174
IV. RECOMMENDATIONS
A. The Need for Legislation
The remedies currently available to private sector employees or applicants
wronged by either their employers or the laboratory that performed the test are limited
and inadequate. Scant recourse is available to an applicant screened out before the
hiring process is complete. 175 While terminated employees might sue either their
employers for wrongful discharge, intentional infliction of emotional distress,
invasion of privacy, or defamation, or the laboratory for negligent testing, these
avenues are costly, time consuming, and difficult to prove. Even reinstatement or a
damage award might fail to erase the stigma that charges of drug abuse can cause. 176
As drug testing becomes more commonplace in today's workplace, even a tiny
margin of error in the testing procedure has the potential to harm increasingly greater
numbers of people. 177 Rather than requiring the victims of erroneous testing to use the
171. Id. at 232.
172. Id.
173. Id.
174. Note, supra note 69, at 287.
175. "IM]onumental changes in the at-will doctrine will be required before anything even approaching a good-cause
standard can be applied to employer hiring decisions .... M. Romaesr, supra note 14, at 83. The Atlantic Richfield
Company allows job applicants who test positive for marijuana to receive conditional employment based on a six-month
period of negative test results. Loomis, supra note 88, at 134.
176. Many arbitrators apply a stricter standard of proof in drug cases than in alcohol cases. The rationale for this
is that "matters carrying the 'stigma' of criminal conduct or of general social disapproval must be applied with an
especially high degree of fairness supported by strong proof. Arbitrators have also noted that an employee discharged for
such an offense may have greater difficulty finding another job, thus making it imperative that the employer be correct
in its accusations." Geidt, Drug and Alcohol Abuse in the Work Place: Balancing Employer and Employee Rights, 11
EMPLOYEE R LATioNs L.J. 181, 193-94 (1986).
177. A recent study of fifty drug testing laboratories by the National Institute on Drug Abuse reveals that twenty
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courts in a rear-guard action to vindicate their rights, legislation is needed to regulate
drug testing both as a condition of initial employment and as a condition of continuing
employment. 178
On September 15, 1986, President Reagan issued an executive order mandating
drug testing for federal workers. 179 The executive order states that:
Drug testing programs shall contain procedures for timely submission of requests for
retention of records and specimens; procedures for retesting; and procedures, consistent with
applicable law, to protect the confidentiality of test results and related medical and
rehabilitation records .... 1C0 Preliminary test results may not be used in an administrative
proceeding unless they are confirmed by a second analysis of the same sample or unless the
employee confirms the accuracy of the initial test by admitting the use of illegal drugs. 18,
As a result of Executive Order 12,564, the Department of Health and Human
Services proposed specific drug testing guidelines for federal agencies. 18 2 These
guidelines attempt to safeguard the testing process and ensure that testing is performed
by competent laboratories. The guidelines might also serve as a model for state
legislatures contemplating regulation of drug testing laboratories. Despite these
proposed guidelines, however, slipshod and disreputable laboratories continue to
operate, sometimes with disasterous consequences.
One recent debacle involved the federal laboratory that conducted drug tests
following the worst railroad accident in Amtrak history. Investigation revealed that
the laboratory fabricated the blood tests of the engineer involved in the train crash. 183
Neither the laboratory supervisor, nor other laboratory personnel, knew how to
correctly operate their gas chromatograph/mass spectrometer. Laboratory personnel
did not even know how to extract a test sample from blood plasma. The laboratory
workers used improperly calibrated instruments, lost the computer data backing their
findings, and squandered the engineer's entire blood sample. 184 Consequently,
retesting by a competent laboratory could not be done. This incident merely
underscores the need to regulate both the drug testing facilities and the laboratory
personnel.
Since the issuance of the executive order, and the sudden death of college
basketball star Len Bias, there has been an upsurge of interest and support for
compulsory drug testing, particularly in pre-election speeches by political figures. 185
Consequently, it is now imperative that state legislatures pass protective drug testing
legislation. Nothing less can ensure adherence to proper standards of care by those
percent of the laboratories erroneously reported the presence of drugs in urine specimens. False negatives were reported
in eleven percent of the samples. 1 Emp Testing: Biweekly Rep. (Univ. Pub. of Amer.) 36 (May 15, 1987).
178. See Note, supra note 69, at 287.
179. Exec. Order No. 12,564, 51 Fed. Reg. 32,889 (1986).
180. Id. at § 4.[c].
181. Id. at § 5.le].
182. Fed. Reg. 30,637 (1987) (proposed Aug. 4, 1987).
183. Bogdanich, Federal Lab Studying Train, Airline Crashes Fabricated Its Findings, Wall Street J., July 31,
1987, at 12.
184. Id.
185. Curran, Compulsory Drug Testing: The Legal Barriers, 316 NEw FG. J. MED. 318-19 (Feb. 5, 1987).
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performing the tests. Nothing less can protect the rights of millions of workers who
may be involved in a testing program in the near future.
A number of states have passed or are considering such legislation.186 But for the
most part, private laboratories conducting drug detection testing in the United States
are generally not compelled to comply with specific guidelines to ensure accurate
results. 187 The laboratories conducting these programs need to meet standards of
quality control, chain of custody, technical expertise, and documented proficiency
over time in urinalysis testing. 8 8 Otherwise, innocent workers risk being labeled
drug users on the basis of inaccurate results.
B. Legislative Guidelines
Legislation should deal with the problems of specimen integrity and accuracy of
test results, specifically as they apply to both pre-employment and on-the-job
screening. Employers should be required to have samples tested by state-licensed
laboratories and to maintain adequate quality assurance programs. 89 Quality assur-
ance programs are documented procedures which the laboratory follows to ensure
reliability by controlling the way specimens are handled, and how instruments are
checked to be sure they are functioning properly. The programs also involve
analyzing standard samples and blank samples along with unknown samples to see if
the total laboratory system is producing the expected results.190 Currently, in most
states, "[a]nybody can buy a portable testing unit and hang out a shingle claiming to
be operating a drug testing lab." 191 It costs money to belong to these quality
assurance programs, and there is a danger that some laboratories may not want to
know how good or bad their work might be. 192 Also, a company may decide to begin
a drug testing program and shop around for a laboratory that will do the work at a
rock-bottom price. 193 Legislation requiring that all testing be performed by accredited
laboratories can help eliminate the fly-by-night instant toxicologists; such a step
would also allow reputable laboratories to compete on an equal basis.
All initially positive drug screens should require confirmation by an alternate
method prior to the commencement of any disciplinary actions, and gas
chromatography/mass spectrometry (GC/MS) confirmation procedures should be
186. Connecticut requires an initial positive result to be confirmed by a second urinalysis, and that positive result
must be confirmed by gas chromatography/mass spectrometry or an equally reliable method. The new law also prohibits
direct observation of urination. 1987 Conn. Legis. Serv. 500-02 (West). Iowa requires that an initially positive result be
confirmed by a second test using an alternative method of analysis. 1987 Iowa Legis. Serv. 132-36 (Vest). Minnesota
has an extensive statute that regulates laboratories, testing procedures, reporting, sample retention, chain-of-custody, and
confidentiality. 1987 Minn. Sess. Law Serv. 768-86 (West). New Jersey has recently enacted the Pre-employment and
Employment Drug Testing Standards Act which was unavailable as of this writing. Utah has a vaguely worded statute that
does, however, require confirmation by gas chromatography or gas chromatography/mass spectrometry before the result
can be used as the basis of disciplinary or rehabilitative action. UrA CoDE ANN. §§ 34-38-1-38-15 (Supp. 1987).
California SB1611 is pending. For recent developments in this rapidly changing area, see 9A LAB. REi.. REP. (BNA) 540.
187. NAIONAL INsIrrrtE ON DRUG ABusE, supra note 14, at 3.
188. Id.
189. These programs regulate internal and external quality control procedures. Hanson, supra note 2, at 12.
190. NAnO AL INsTITUTE ON DRUG ABUSE, supra note 14, at 16-17.
191. Hanson, supra note 2, at 12.
192. Id.
193. Stille, supra note 7, at 24.
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required for all positive samples where the employee faces termination. This assures
that the burden of proving drug use is on the employer. Arbitrators have recognized
the need for placing the burden of proof on the employer in cases involving disciplinary
action. One arbitrator articulated the reasons for this in the following manner:
(1) [s]ince discharge is the most severe penalty that an employer can impose, being the
equivalent of "economic capital punishment," he must bear the burden of justifying such a
serious move; (2) since the reasons for the employer's disciplinary action are peculiarly
within his own knowledge, he must carry the burden of demonstrating their adequacy; (3)
it is inconsistent with the American tradition that a person should be considered a wrongdoer
until proof establishes his guilt; (4) the imposition of the burden of proof on the employer
is justifiable as merely an extension of scientific management to industrial relations; (5) the
existence of just cause for discharge is in the nature of an affirmative defense; therefore the
burden rests on the party asserting it; and (6) a just cause provision in the agreement in view
of circumstances peculiar to industrial relations requires the company, when challenged, to
retrace the disciplinary process and convince an impartial third person that the facts acted
upon warranted the action taken. ,94
While the employer should bear the cost of one repeat test and GC/MS
confirmation of disputed positive results, further testing of a disputed result could be
at the employee's expense. Requiring employees to bear the cost of additional
confirmatory testing would discourage frivolous disputes over test results.
The laboratories should be required to provide the employers with collection
bottles, seals, shipping containers, and chain-of-custody forms to be filled out at the
collection point. 195 The employer and testing laboratory must comply with proper
chain-of-custody procedures and have the capacity to freeze positive samples for up
to six months to allow time for retesting if results are challenged. 196 Following proper
chain-of-custody and specimen handling procedures would not only assist the
employer in any subsequent litigation, but it would also help to ensure the accuracy
and integrity of test results.
V. CONCLUSION
In order to demonstrate the need for legislation designed to decrease erroneous
drug test results, this Article has examined current drug testing methodology and the
debate over the reliability of the tests. Although the reliability issue is still far from
settled, challenges have already begun to reach the courts since drug testing is
becoming an increasingly common occurrence in contemporary society. Both
employees and employers can benefit from legislation designed to limit testing abuse,
rather than wait for further ad hoc development in the courts.
Marianne Neal
194. BEsrmo, supra note 8, at 9 (quoting Hussman Refrigerator Co., 68 Lab. Arb. (BNA) 565, 569 (1977)).
195. NAnON,AL INrnurE oN DREO ABUSE, supra note 14, at 16, 24-25.
196. Id. at 15.
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